Scientific studies of why foods such as Brussels sprouts and stout beer are horribly bitter-tasting to some people but palatable to others are shedding light on a number of questions, from the mechanisms of natural selection to understanding how our genes affect our dietary habits.
Two reports have been published today in response to the outbreak of avian influenza in Suffolk.
Ensuring the health of pregnant women and their children would form an important part of a new review of the national guidelines on alcohol consumption, the Assistant Minister for Health and Ageing, Christopher Pyne, said today.
Irritable bowel syndrome (IBS) is a common gastrointestinal disorder in the developed world. It is characterized by altered bowel function, abdominal discomfort, and pain.
In a first-of-its-kind trans-Atlantic effort to address cancer disparities among Nigerian and Nigerian-American populations, The University of Texas M. D. Anderson Cancer Center, the Health Disparities Education, Awareness, Research & Training Consortium (HDEART) and the Ministry of Health of the Federal Republic of Nigeria today signed a Memorandum of Understanding (MOU), forming a partnership to collaborate on cancer research, education and training programs in Nigeria.
Slow-release morphine helped a group of patients with long-term, treatment-resistant chronic cough reduce their daily cough score levels by 40 percent.
A study published in the Feb. 15 issue of the Journal of Clinical Sleep Medicine (JCSM) finds that adolescents who experience sleep disturbances are more likely to receive bad grades in school.
Government initiatives making sexual health a priority are not reaching many local services, a survey from Terrence Higgins Trust and professional associations shows today.
Men who have had a vasectomy may face an increased risk of developing a rare type of dementia, Northwestern University researchers discovered.
The first “antisense” drug to be tested in chronic lymphocytic leukemia (CLL) shows benefit in a phase III clinical trial for a specific subset of patients – those who are still sensitive to a chemotherapy drug often used to treat this cancer.